KALA BIO
Kala Pharmaceuticals Logo
About Kala Pharmaceuticals
KALA BIO, Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for rare and severe eye diseases. The company leverages proprietary drug delivery technology to develop treatments such as KPI-012, currently in Phase 2b clinical trials for persistent corneal epithelial defects, and KPI-014, a preclinical candidate for rare inherited retinal diseases. Formerly known as Kala Pharmaceuticals, Inc., the company changed its name to KALA BIO, Inc. in August 2023 and is headquartered in Arlington, Massachusetts.
Address
1167 Massachusetts Avenue,
Arlington, 02476
United States
Year founded
2009
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
